Multani Pratik S 4
4 · Oric Pharmaceuticals, Inc. · Filed Jan 3, 2025
Insider Transaction Report
Form 4
Multani Pratik S
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2025-01-02+202,500→ 202,500 totalExercise: $8.26Exp: 2035-01-01→ Common Stock (202,500 underlying) - Award
Restricted Stock Unit
2025-01-02+34,000→ 34,000 total→ Common Stock (34,000 underlying)
Footnotes (3)
- [F1]25% of the shares subject to the option shall vest on January 2, 2026, and 1/36th of the remaining shares subject to the option shall vest each month thereafter.
- [F2]Each restricted stock unit ("RSU") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. Common Stock.
- [F3]1/3rd of the RSUs subject to the award shall vest on each of December 15, 2025, December 15, 2026 and December 15, 2027.